Vesna Cemerikic Martinovic
Overview
Explore the profile of Vesna Cemerikic Martinovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
The presence of Mott cells in the lymph nodes of rats with experimental autoimmune encephalomyelitis
Martinovic T, Vidicevic S, Ciric D, Bumbasirevic V, Stanojevic Z, Tasic J, et al.
Histochem Cell Biol
. 2023 Nov;
161(3):287-295.
PMID: 37952208
Mott cells are plasma cells that have multiple spherical Russell bodies packed in their cytoplasm. Russell bodies are dilated endoplasmic reticulum cisternae filled with aggregates of immunoglobulins that are neither...
2.
Perunicic Jovanovic M, Mihaljevic B, Jovanovic P, Jelicic J, Martinovic V, Jovanovic J, et al.
Pol J Pathol
. 2018 Oct;
69(2):136-142.
PMID: 30351860
Primary testicular diffuse large B-cell lymphoma (PT-DLBCL) represents a rare and aggressive extranodal non-Hodgkin's lymphoma (NHL) with some specific features that differ from other NHLs. Formalin fixed, paraffin wax embedded...
3.
Zeremski V, Savic A, Martinovic V, Milosevic I, Dragicevic M, El Farra A
Med Pregl
. 2018 Apr;
69(11-12):376-378.
PMID: 29693864
Case Report: A 41-year-old man presented with anemia, lymphocytosis and splenoniegaly. T-cell large granular lymphocyte leukemia was diagnosed based on lymphocytosis of T-cell large granular lymphocytes, characteristic inimunophenotype (CD)3⁺ CD8⁺,...
4.
Perunicic Jovanovic M, Mihaljevic B, Jakovic L, Martinovic V, Dencic Fekete M, Andjelic B, et al.
J BUON
. 2015 Jul;
20(3):820-8.
PMID: 26214636
Purpose: Despite major advances in the treatment of diffuse large B cell lymphoma (DLBCL), approximately one third of the patients progress or die, suggesting the existence of additional oncogenic events....
5.
Perunicic Jovanovic M, Jakovic L, Bogdanovic A, Markovic O, Martinovic V, Mihaljevic B
Vojnosanit Pregl
. 2009 Nov;
66(9):738-43.
PMID: 19877554
Background/aim: Newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL) tretaed with immunochemotherapy have durable remission and improved overall survival. It is important to identify high risk patients who may...